Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials
Zenith Annual General Meeting of Shareholders
Tuesday, December 12, 2017 2:45pm MT
Webcast Link
If that link doesn't work, please go to the Zenith Events page and click on the appropriate link.